198 related articles for article (PubMed ID: 37186766)
41. Regional citrate versus heparin anticoagulation for continuous renal replacement therapy in critically ill patients: A meta-analysis of randomized controlled trials.
Li R; Gao X; Zhou T; Li Y; Wang J; Zhang P
Ther Apher Dial; 2022 Dec; 26(6):1086-1097. PubMed ID: 35385216
[TBL] [Abstract][Full Text] [Related]
42. [Citrate: a different mental approach to extracorporeal circuit anticoagulation].
Mariano F
G Ital Nefrol; 2012; 29(1):27-32. PubMed ID: 22388903
[TBL] [Abstract][Full Text] [Related]
43. Regional citrate anticoagulation for continuous renal replacement therapy in newborns and infants: Focus on citrate accumulation.
Persic V; Vajdic Trampuz B; Medved B; Pavcnik M; Ponikvar R; Gubensek J
Artif Organs; 2020 May; 44(5):497-503. PubMed ID: 31851381
[TBL] [Abstract][Full Text] [Related]
44. Safety and efficacy of regional citrate anticoagulation in continuous blood purification treatment of patients with multiple organ dysfunction syndrome.
Tuerdi B; Zuo L; Sun H; Wang K; Wang Z; Li G
Braz J Med Biol Res; 2017 Nov; 51(1):e6378. PubMed ID: 29185591
[TBL] [Abstract][Full Text] [Related]
45. Comparison of curative effect between different anticoagulation regimens in continuous renal replacement therapy after cardiac valve replacement.
Ren H; Song C; Wu Y; Ouyang C; Ye X; Huang L
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 Aug; 45(8):941-947. PubMed ID: 33053536
[TBL] [Abstract][Full Text] [Related]
46. Complications of regional citrate anticoagulation: accumulation or overload?
Schneider AG; Journois D; Rimmelé T
Crit Care; 2017 Nov; 21(1):281. PubMed ID: 29151020
[TBL] [Abstract][Full Text] [Related]
47. [Citrate anticoagulation in acute renal replacement therapy : Method of choice].
Frank RD
Med Klin Intensivmed Notfmed; 2014 Jun; 109(5):336-41. PubMed ID: 24844156
[TBL] [Abstract][Full Text] [Related]
48. Applying Regional Citrate Anticoagulation in Continuous Renal Replacement Therapy for Acute Kidney Injury Patients with Acute Liver Dysfunction: a Retrospective Observational Study.
Yu Y; Peng S; Cen Z; Cai J; Wang W; Tang Y; Du M; Liu Z; Chang P
Kidney Blood Press Res; 2018; 43(4):1065-1074. PubMed ID: 29969768
[TBL] [Abstract][Full Text] [Related]
49. Development of a Multivariable Prediction Model for Citrate Accumulation in Liver Transplant Patients Undergoing Continuous Renal Replacement Therapy with Regional Citrate Anticoagulation.
Xin X; Tang J; Jia HM; Zhang TE; Zheng Y; Huang LF; Ding Q; Li JC; Guo SY; Li WX
Blood Purif; 2022; 51(2):111-121. PubMed ID: 33951630
[TBL] [Abstract][Full Text] [Related]
50. Regional citrate anticoagulation in critically ill patients with liver and kidney failure.
Balogun RA; Turgut F; Caldwell S; Abdel-Rahman EM
J Nephrol; 2012; 25(1):113-9. PubMed ID: 21607918
[TBL] [Abstract][Full Text] [Related]
51. Regional citrate anticoagulation using a citrate-based substitution solution for continuous venovenous hemofiltration in cardiac surgery patients.
Thoenen M; Schmid ER; Binswanger U; Schuepbach R; Aerne D; Schmidlin D
Wien Klin Wochenschr; 2002 Feb; 114(3):108-14. PubMed ID: 12060967
[TBL] [Abstract][Full Text] [Related]
52. Application of regional citrate anticoagulation in membrane therapeutic plasma exchange.
Yuan F; Li Z; Li X; Liu H
Int Urol Nephrol; 2020 Dec; 52(12):2379-2384. PubMed ID: 32740788
[TBL] [Abstract][Full Text] [Related]
53. Safety of regional citrate anticoagulation for continuous sustained low efficiency dialysis (C-SLED) in critically ill patients.
Finkel KW; Foringer JR
Ren Fail; 2005; 27(5):541-5. PubMed ID: 16152991
[TBL] [Abstract][Full Text] [Related]
54. [Effects of citric acid on patients with severe burn complicated with acute renal injury treated by continuous renal replacement therapy].
Li XL; Xiao HT; Li YC; Li YG; Zhang J; Feng K; Di HP; Tian SM; Lou JH; Xia CD
Zhonghua Shao Shang Za Zhi; 2019 Aug; 35(8):568-573. PubMed ID: 31474035
[No Abstract] [Full Text] [Related]
55. Citrate versus unfractionated heparin for anticoagulation in continuous renal replacement therapy.
Liao YJ; Zhang L; Zeng XX; Fu P
Chin Med J (Engl); 2013 Apr; 126(7):1344-9. PubMed ID: 23557569
[TBL] [Abstract][Full Text] [Related]
56. Evaluation of the efficacy and associated complications of regional citrate anticoagulation in neonates: experience from a fourth level neonatal intensive care unit.
Köstekci YE; Kendirli T; Gün E; Uçmak H; Demirtaş F; Havan M; Köse E; Okulu E; Eminoğlu FT; Erdeve Ö; Atasay B; Arsan S
Eur J Pediatr; 2023 Nov; 182(11):4897-4908. PubMed ID: 37597047
[TBL] [Abstract][Full Text] [Related]
57. Regional Citrate Anticoagulation for Continuous Kidney Replacement Therapy With Calcium-Containing Solutions: A Cohort Study.
Rhee H; Berenger B; Mehta RL; Macedo E
Am J Kidney Dis; 2021 Oct; 78(4):550-559.e1. PubMed ID: 33798636
[TBL] [Abstract][Full Text] [Related]
58. Heparin anticoagulation versus regional citrate anticoagulation for membrane therapeutic plasma exchange in patients with increased bleeding risk.
Jiao J; Yu Y; Wei S; Tian X; Yang X; Feng S; Li Y; Sun S; Zhang P; Bai M
Ren Fail; 2023 Dec; 45(1):2210691. PubMed ID: 37183868
[No Abstract] [Full Text] [Related]
59. Regional citrate anticoagulation for continuous renal replacement therapy.
Kindgen-Milles D; Brandenburger T; Dimski T
Curr Opin Crit Care; 2018 Dec; 24(6):450-454. PubMed ID: 30247214
[TBL] [Abstract][Full Text] [Related]
60. A noninferiority trial comparing a heparin-grafted membrane plus citrate-containing dialysate versus regional citrate anticoagulation: results of the CiTED study.
Meijers B; Metalidis C; Vanhove T; Poesen R; Kuypers D; Evenepoel P
Nephrol Dial Transplant; 2017 Apr; 32(4):707-714. PubMed ID: 28407129
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
